As with people, identity is vital to cells. When a cell loses its identity, it can stop working properly and a range of illnesses can result. The immune system, which protects our bodies from disease, includes cells with many different identities. When these cells lose their identity it can cause certain cancers or increase the risk of infections.
Complex networks of signals and genes create and maintain the identity of different cells. New research from the Babraham Institute, Cambridge and the University of Birmingham has revealed how a protein called ZFP36L1 helps cells known as marginal zone B cells (MZ B cells) to maintain their identity.
For cells, identity describes how they are adapted to have a specialised function. Blood cells are specialised for transportation, nerve cells for communication and the immune system fights infections. Each cell becomes specialised to do its job as a result of unique combinations of genetic instructions, which influence how the cell works.
MZ B cells play an important role in the early stages of preventing infection, by screening blood that passes through the spleen for signs of invading germs that might cause an illness. Without these cells, our body would be at much greater risk of illness.
In a paper out today in the journal Nature Immunology, the team, led by Dr Martin Turner showed that, by blocking the translation of certain genetic instructions, ZFP36L1 helps MZ B cells to keep the correct identity. By working together with Professor Gurdyal Besra and Dr Adam Cunningham in Birmingham, the team have shown that ZFP36L1 ensures MZ B cells continue to communicate, move and interact correctly.
Many proteins that control the identity of cells act by interacting with DNA to switch genes on or off – silencing key genetic instructions. ZFP36L1 is different, it doesn’t shut down the genes but instead it stops their messages getting through to the rest of the cell.
Genes act as stores of information, but to have an effect on the cell they must be switched on. These active genes produce molecular messages called mRNA, which carry their instructions to other parts of the cell, where the instructions they carry are used to make proteins. Through proteins, genes influence how cells work. In MZ B cells, ZFP36L1 stops certain mRNA messages from getting through. This means the cells don’t produce certain proteins that could change their identity.
As lead author on the paper Rebecca Newman, now a post-doctoral scientist at the Francis Crick Institute in London explained: “ZFP36L1 plays an important role in MZ B cells by controlling the levels of mRNA from genes such as IRF8 and KLF2. If ZFP36L1 is lost, MZ B cells leave the marginal zone of the spleen and many of them die.”
The paper’s senior author and Head of the Lymphocyte Signalling and Development research programme at the Babraham Institute, Martin Turner said: “Our immune system contains many different types of cells with unique roles. Extremely complex processes govern the development and function of each of these cell types. This study adds to our understanding of the multi-level control over cellular identity for cells in the immune system.”
This work highlights the importance of proteins like ZFP36L1, which regulate multiple mRNA messages. Further understanding how ZFP36L1 and other similar proteins function and are controlled in MZ B cells could be important in autoimmune diseases – where the immune system attacks the rest of the body – and certain types of lymphoma.
This paper is also the focus of a Nature Immunology News & Views article titled "RNA-binding proteins, the guardians of the marginal zone" by Palaniraja Thandapani, Beatriz Aranda-Orgilles and Iannis Aifantis from New York University.
Newman, R. et al., Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1., Nat. Immunol. 18, 683–693 (2017). doi:10.1038/ni.3724
This work was funded by a GSK-CASE studentship with additional support from the Biotechnology and Biological Sciences Research Council, The Medical Research Council and Bloodwise.
Dr Jonathan Lawson, Babraham Institute Communications Managerjonathan.firstname.lastname@example.org
Image source: Dr Becky Newman
Mouse spleen cells lacking ZFP36L1. Loss of ZFP36L1 causes marginal zone B cells (magenta) to move into spleen follicles, which consist of follicular B cells (blue) and surrounded by metallophilic macrophages (green).
Affiliated Authors (in author order):
Rebecca Newman, Helena Ahlfors, Alexander Saveliev, Alison Galloway, Robert Williams, Sarah Bell Immunology Programme, Babraham InstituteMartin Turner, Group Leader, Immunology Programme, Babraham Institute
About the Babraham Institute:
The Babraham Institute receives strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC) to undertake world-class life sciences research. It's goal is to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. Research focuses on signalling, gene regulation and the impact of epigenetic regulation at different stages of life. By determining how the body reacts to dietary and environmental stimuli and manages microbial and viral interactions, we aim to improve wellbeing and support healthier ageing.
Animal research statement:
As a publically funded research institute and a signatory of the Concordat on Openness in Animal Research, the Babraham Institute is committed to engagement and transparency in all aspects of its research. The research presented here used mice that were bred in the Institute’s Animal Facility. Lymphocyte numbers and functions were measured in adult mice.
All animal work was approved by the Babraham Institute Animal Welfare and Ethical Review Body, and carried out in accordance with the Animals (Scientific Procedures) Act 1986, under a UK Home Office project licence. This work adhered to the principles of the 3Rs (reduction, refinement, replacement) of animal research. Details of the mice used in these studies can be found in the methods section and the figure legends of the paper.
Please follow the link for further details of the Institute’s animal research and our animal welfare practices.
19 May 2017